Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is set to present comprehensive AA Signature™ multimodal treatment approach to global audience, at the upcoming Internationally recognized Aesthetic Anti-Aging Medicine World Congress (AMWC), taking place in Dubai from Wednesday 1 – Friday 3 October 2025.
The AA Signature treatment approach harnesses Allergan Aesthetics’ leading product portfolio and is supported by advanced education and business resources for healthcare professionals. Designed to meet evolving patient needs and enhance clinical practice, AA Signature has been successfully launched in over 25 countries this year and is planned for further expansion. The protocol-driven methodology currently addresses different globally recognized patient needs including Lift Up, Distinct Definition, and improved skin quality.
“Aesthetic trends worldwide are shifting toward a more natural, individualized look. The AA Signature™ treatment approach is designed to meet these emerging patient needs, offering a holistic method that recognizes and aligns with each patient’s unique goals. The approach leverages Allergan Aesthetics’ advanced and versatile portfolio to empower healthcare professionals to deliver multimodal treatment plans for tailored results, strengthening patient relationships and encouraging long-term retention,” said Mark Wilson, SVP, International Allergan Aesthetics. We’ve received excellent feedback from healthcare practitioners since launching AA Signature™, and we look forward to continuing to showcase real-world results and data in the coming months.”
